For patients who cannot tolerate hydroxyurea or for whom it is not suitable, alternatives include other chemotherapeutic agents, bone marrow transplants, and gene therapy. Specifically for SCD, new treatments like L-glutamine and voxelotor are emerging as alternatives, albeit with different mechanisms of action and efficacy profiles.
